Clinical study on the treatment of constipation with defecation disorder by injection of softener under colonoscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037721

Enrollment

Unknown

Registered

2020-08-30

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Interventions

Treatment group:Injection softener

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Ages 18-75, regardless of gender; (2) Constipation with defecation disorder: constipation due to rectal mucosal prolapse, rectal prolapse, varicose internal hemorrhoids; (3) Subjects voluntarily sign written informed consent; (4) Good compliance.

Exclusion criteria

Exclusion criteria: (1) Patients who received injection therapy such as shardening agent or xiaozhiling within 3 months before the test; (2) Patients with colorectal cancer or other cancers and expected survival rate < 24 months; (3) women during pregnancy; (4) Patients with acute infectious inflammation of the rectum or anal canal; (5) The researcher judges other persons who are not suitable for inclusion.

Design outcomes

Primary

Measure	Time frame
Defecation is difficult and strenuous;Fecal character;Defecation time min/ time;	—

Secondary

Measure	Time frame
frequency/time;	—

Countries

China

Contacts

Public Contactcuiping yang

Ruijin North hospital, School of Medicine, Shanghai Jiaotong University

yangcuipingsgh@163.com+86 18121267023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026